It has been reported that CDDO-Me, a synthetic triterpenoid, could inhibit NFκB activation in human leukemia cell lines and led to down-regulate of NFκB target genes which involved in anti-apoptosis, proliferation or angiogenesis [32]. Here, NFKB1 is linked to leukemia.